{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:40:24Z","timestamp":1742971224013,"version":"3.40.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,25]]},"DOI":"10.7759\/cureus.81207","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:05:57Z","timestamp":1742969157000},"source":"Crossref","is-referenced-by-count":0,"title":["Successful Outpatient Treatment of Legionella pneumophila Pneumonia With Lascufloxacin: A Case Report"],"prefix":"10.7759","author":[{"given":"Jun","family":"Hirai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-066721","article-title":"Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis","volume":"13","author":"Wang S","year":"2023","unstructured":"Wang S, Tang J, Tan Y, Song Z, Qin L. Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis. BMJ Open. 2023, 13:e066721. 10.1136\/bmjopen-2022-066721","journal-title":"BMJ Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.4852-20","article-title":"Legionellosis in Japan: a self-inflicted wound?","volume":"60","author":"Tanimoto T","year":"2021","unstructured":"Tanimoto T, Takahashi K, Crump A. Legionellosis in Japan: a self-inflicted wound?. Intern Med. 2021, 60:173-80. 10.2169\/internalmedicine.4852-20","journal-title":"Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-022-00635-7","article-title":"Legionnaires' disease: update on diagnosis and treatment","volume":"11","author":"Viasus D","year":"2022","unstructured":"Viasus D, Gaia V, Manzur-Barbur C, Carratal\u00e0 J. Legionnaires' disease: update on diagnosis and treatment. Infect Dis Ther. 2022, 11:973-86. 10.1007\/s40121-022-00635-7","journal-title":"Infect Dis Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00120-17","article-title":"In vitro activities and spectrum of the novel fluoroquinolone Lascufloxacin (KRP-AM1977)","volume":"61","author":"Kishii R","year":"2017","unstructured":"Kishii R, Yamaguchi Y, Takei M. In vitro activities and spectrum of the novel fluoroquinolone Lascufloxacin (KRP-AM1977). Antimicrob Agents Chemother. 2017, 61:10.1128\/AAC.00120-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02169-17","article-title":"Intrapulmonary pharmacokinetics of Lascufloxacin in healthy adult volunteers","volume":"62","author":"Furuie H","year":"2018","unstructured":"Furuie H, Tanioka S, Shimizu K, Manita S, Nishimura M, Yoshida H. Intrapulmonary pharmacokinetics of Lascufloxacin in healthy adult volunteers. Antimicrob Agents Chemother. 2018, 62:10.1128\/AAC.02169-17","journal-title":"Antimicrob Agents Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.09.010","article-title":"Pharmacokinetic study of Lascufloxacin in non-elderly healthy men and elderly men","volume":"26","author":"Totsuka K","year":"2020","unstructured":"Totsuka K, Sesoko S, Fukase H, Ikushima I, Odajima M, Niwayama Y. Pharmacokinetic study of Lascufloxacin in non-elderly healthy men and elderly men. J Infect Chemother. 2020, 26:231-9. 10.1016\/j.jiac.2019.09.010","journal-title":"J Infect Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15030804","article-title":"Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?","volume":"15","author":"Rusu A","year":"2023","unstructured":"Rusu A, Munteanu AC, Arb\u0103na\u0219i EM, Uivarosi V. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15030804","journal-title":"Pharmaceutics"},{"key":"ref8","unstructured":"Adult pneumonia treatment guidelines 2024. (2024). Accessed. March 1, 2025: https:\/\/www.jrs.or.jp\/publication\/jrs_guidelines\/20240319125656.html."},{"key":"ref9","unstructured":"JAID\/JSC infectious disease treatment guide 2023. (2023). Accessed. March 1, 2025: https:\/\/www.kansensho.or.jp\/modules\/journal\/index.php?content_id=11."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.07.089","article-title":"International perspective on the new 2019 American Thoracic Society\/Infectious Diseases Society of America community-acquired pneumonia guideline: a critical appraisal by a global expert panel","volume":"158","author":"Pletz MW","year":"2020","unstructured":"Pletz MW, Blasi F, Chalmers JD, et al.. International perspective on the new 2019 American Thoracic Society\/Infectious Diseases Society of America community-acquired pneumonia guideline: a critical appraisal by a global expert panel. Chest. 2020, 158:1912-8. 10.1016\/j.chest.2020.07.089","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2024.05.011","article-title":"Three cases of hospitalized Legionella pneumonia patients successfully treated with Lascufloxacin","volume":"31","author":"Ito A","year":"2025","unstructured":"Ito A, Kawataki M, Sato R, Nakanishi Y, Ishida T. Three cases of hospitalized Legionella pneumonia patients successfully treated with Lascufloxacin. J Infect Chemother. 2025, 31:102431. 10.1016\/j.jiac.2024.05.011","journal-title":"J Infect Chemother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2019.03.009","article-title":"Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia","volume":"25","author":"Miyashita N","year":"2019","unstructured":"Miyashita N, Horita N, Higa F, et al.. Validation of a diagnostic score model for the prediction of Legionella pneumophila pneumonia. J Infect Chemother. 2019, 25:407-12. 10.1016\/j.jiac.2019.03.009","journal-title":"J Infect Chemother"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.4.573","article-title":"Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy","volume":"40","author":"Andrews JM","year":"1997","unstructured":"Andrews JM, Honeybourne D, Jevons G, Brenwald NP, Cunningham B, Wise R. Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy. J Antimicrob Chemother. 1997, 40:573-7. 10.1093\/jac\/40.4.573","journal-title":"J Antimicrob Chemother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S453634","article-title":"Effectiveness of drip infusion of Lascufloxacin, a novel fluoroquinolone antibiotic, for patients with pneumonia including chronic lung disease exacerbations and lung abscesses","volume":"17","author":"Shimada D","year":"2024","unstructured":"Shimada D, Seki M. Effectiveness of drip infusion of Lascufloxacin, a novel fluoroquinolone antibiotic, for patients with pneumonia including chronic lung disease exacerbations and lung abscesses. Infect Drug Resist. 2024, 17:911-8. 10.2147\/IDR.S453634","journal-title":"Infect Drug Resist"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2020.10.002","article-title":"Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia","volume":"27","author":"Kato H","year":"2021","unstructured":"Kato H, Hagihara M, Asai N, Shibata Y, Koizumi Y, Yamagishi Y, Mikamo H. Meta-analysis of fluoroquinolones versus macrolides for treatment of Legionella pneumonia. J Infect Chemother. 2021, 27:424-33. 10.1016\/j.jiac.2020.10.002","journal-title":"J Infect Chemother"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the Antigenuria era: the influence of levofloxacin therapy","volume":"40","author":"Mykietiuk A","year":"2005","unstructured":"Mykietiuk A, Carratal\u00e0 J, Fern\u00e1ndez-Sab\u00e9 N, Dorca J, Verdaguer R, Manresa F, Gudiol F. Clinical outcomes for hospitalized patients with Legionella pneumonia in the Antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005, 40:794-9. 10.1086\/428059","journal-title":"Clin Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.09.001","article-title":"Clinical presentation of Legionella pneumonia: Evaluation of clinical scoring systems and therapeutic efficacy","volume":"23","author":"Miyashita N","year":"2017","unstructured":"Miyashita N, Higa F, Aoki Y, et al.. Clinical presentation of Legionella pneumonia: Evaluation of clinical scoring systems and therapeutic efficacy. J Infect Chemother. 2017, 23:727-32. 10.1016\/j.jiac.2017.09.001","journal-title":"J Infect Chemother"},{"key":"ref18","article-title":"An overview of oral Lascufloxacin, a novel quinolone antibiotic (Article in Japanese)","volume":"68","author":"Tateda K","year":"2020","unstructured":"Tateda K, Tanioka S, Totsuka K, Kohno S. An overview of oral Lascufloxacin, a novel quinolone antibiotic (Article in Japanese). Jpn J Chemother. 2020, 68:1-15.","journal-title":"Jpn J Chemother"},{"key":"ref19","article-title":"A-DROP system might result in underestimation of severity of cases with Legionnaires' disease (Article in Japanese)","volume":"46","author":"Haranaga S","year":"2008","unstructured":"Haranaga S, Higa F, Tateyama M, et al.. A-DROP system might result in underestimation of severity of cases with Legionnaires' disease (Article in Japanese). Nihon Kokyuki Gakkai Zasshi. 2008, 46:351-5.","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay JP","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al.. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019, 200:e45-e67. 10.1164\/rccm.201908-1581ST","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/352749-successful-outpatient-treatment-of-legionella-pneumophila-pneumonia-with-lascufloxacin-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T06:06:03Z","timestamp":1742969163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/352749-successful-outpatient-treatment-of-legionella-pneumophila-pneumonia-with-lascufloxacin-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.81207","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,25]]}}}